Announcement on Preliminary Earnings Estimate for 2025
Filed with SSE · · 3 pages · Chinese
Sinopep-Allsino Bio Pharmaceutical Co., Ltd. on 6ix
Earlier from Sinopep-Allsino Bio Pharmaceutical
- Announcement on Voluntary Disclosure of Passing GMP Compliance Inspection for Drugs
- JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.: Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD. Earnings Preannouncement for 2025
- Announcement on Using Idle Raised Funds for Cash Management
- Announcement on Progress in Signing a Major Daily Operation Contract
Later from Sinopep-Allsino Bio Pharmaceutical
- Announcement on Voluntary Disclosure of Earnings Preannouncement for Q1 2026
- Announcement on Using Idle Self-owned Funds for Entrusted Wealth Management
- Announcement on Controlling Shareholder and Actual Controller Renewing the Agreement of Persons Acting in Concert
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Implementation of Dividend Distribution for 2025
Follow Sinopep-Allsino Bio Pharmaceutical into a list and get an email when it puts out news.
Follow Sinopep-Allsino Bio Pharmaceutical